AVIEW LCS vs EchoGo Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Coreline Soft
VS
by Ultromics

AI Verdict

AVIEW LCS offers a comprehensive cardiopulmonary assessment from CT scans, focusing on lung cancer screening, COPD, and coronary artery calcification. In contrast, EchoGo Pro specializes in AI-powered analysis of stress echocardiograms for the diagnosis of coronary artery disease. While both tools leverage AI for cardiac diagnosis, they utilize distinct imaging modalities and address different diagnostic workflows within cardiology.

Choose AVIEW LCS if…

Choose AVIEW LCS if your primary need is a comprehensive AI-powered solution for lung cancer screening and multi-organ cardiopulmonary assessment from low-dose CT scans. It is ideal for facilities requiring automated detection and analysis of lung nodules, concurrent quantification of emphysema, and coronary artery calcification scoring, along with automated nodule comparison for follow-up studies.

View AVIEW LCS →

Choose EchoGo Pro if…

Choose EchoGo Pro if your focus is on enhancing and automating the analysis of stress echocardiograms for the diagnosis of coronary artery disease. This cloud-based solution is best suited for cardiology departments seeking near-instant, accurate AI-powered reports to improve diagnostic accuracy and streamline workflows specifically for stress echo interpretations.

View EchoGo Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AVIEW LCS EchoGo Pro
Pricing Subscription or one-off payment Contact vendor for pricing
Deployment Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) Cloud-based (SaaS)
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoGo Pro

EchoGo Pro explicitly highlights its SaaS model, requiring no software installation or extensive training, which suggests a more immediate and user-friendly experience. AVIEW LCS, while offering flexible deployment, doesn't emphasize ease of initial setup in the same way.

Clinical Value

AVIEW LCS

AVIEW LCS offers a broader clinical scope by providing integrated, fully automatic analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan. This multi-organ assessment from one input enhances diagnostic accuracy and streamlines workflows more comprehensively than EchoGo Pro's focused cardiac analysis.

Pricing & Value

AVIEW LCS

AVIEW LCS demonstrates a clearer path to financial value, being integral to Germany's national lung cancer screening program where AI-assisted detection is mandatory for reimbursement. It also mentions a specific CPT code (0721T) for AI-specific quantitative image analysis in the US, indicating established reimbursement pathways.

Enterprise Readiness

AVIEW LCS

AVIEW LCS offers superior deployment flexibility, including cloud, hybrid, local dedicated hardware, and virtualized options. This wide range of deployment choices caters to diverse enterprise IT infrastructures and data governance needs, making it more adaptable for large-scale integration.

Innovation

AVIEW LCS

AVIEW LCS stands out for its innovative approach of performing a comprehensive cardiopulmonary assessment (lung cancer, COPD, and coronary artery calcification) from a single low-dose CT scan. This multi-disease screening capability from one examination represents a significant advancement in diagnostic efficiency.

Support & Docs

Tie

Both companies provide clear channels for customer support, including contact information and dedicated support teams. Ultromics explicitly mentions a 'Clinician User Manual' and 'Operator Manual,' while Coreline Soft offers detailed product descriptions and technical documentation, indicating sufficient resources for users.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AVIEW LCS EchoGo Pro
Name AVIEW LCS EchoGo Pro
Company Coreline Soft Co. Ultromics
Tagline AI-Powered Lung Cancer Screening & Cardiopulmonary Assessment AI-powered echocardiography solutions for enhanced cardiac diagnosis
Primary Focus Lung nodule detection, lung cancer screening, COPD, coronary artery calcification from CT scans Automated stress echocardiography analysis for coronary artery disease diagnosis
Key Feature 1 Automated lung nodule detection and analysis AI-powered automated echocardiogram analysis
Key Feature 2 Lung-RADS classification and reporting Automated identification of coronary artery disease (CAD)

Videos

Demos, reviews, and walkthroughs featuring AVIEW LCS and EchoGo Pro.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AVIEW LCS is an AI-powered solution for detecting and analyzing lung nodules, lung cancer, COPD, and coronary artery calcification from low-dose CT scans. EchoGo Pro, on the other hand, is an AI-powered cloud solution that automates stress echocardiography analysis to improve the diagnosis of coronary artery disease.
AVIEW LCS supports a broader range of specialties including Cardiology, Oncology, Pulmonology, and Radiology. EchoGo Pro is specifically designed for Cardiology.
AVIEW LCS offers integration with PACS/RIS and third-party platforms. EchoGo Pro is a vendor-neutral system compatible with any PACS and offers seamless integration with existing clinical workflows via DICOM and HL7.
AVIEW LCS provides automated lung nodule detection and analysis, Lung-RADS classification and reporting, nodule volume quantification and 3D segmentation, emphysema quantification (LAA index), and Coronary Artery Calcification (CAC) scoring. EchoGo Pro offers AI-powered automated echocardiogram analysis and automated identification of coronary artery disease.
EchoGo Pro mentions that reimbursement codes are available for related EchoGo products, such as CPT 0932T for EchoGo Heart Failure and NTAP XXE2X19 for inpatient settings. AVIEW LCS does not specify reimbursement codes in its description, though it mentions automatically generated reports for insurance reimbursement.
AI Tool Finder
AI-powered search. Results may not be comprehensive.